Britain's main indexes fell on Wednesday, with healthcare and real estate stocks leading the decline despite positive trade talk developments, while investor attention turning to the U.S. Federal Reserve's imminent interest rate decision.
By 1008 GMT, the FTSE 100 was down 0.3%. The domestically focused midcap index slipped 0.2%, on track to break its nine-session upward run.
An index of the UK's healthcare companies dropped 2% after the U.S. Food and Drug Administration named Vinay Prasad, an oncologist who has previously criticised FDA leadership and COVID-19 mandates, as the director of its Centre for Biologics Evaluation and Research.
Comments
Post a Comment